Accueil   Diary - News   All news Valneva: 2 licences agreements in Japan

Valneva: 2 licences agreements in Japan

European biotechnology company Valneva  announced that it has signed two new research agreements in Japan to develop human and veterinary vaccines in Valneva’s EB66® cell line.

 

The first license agreement was signed with a global pharmaceutical company, which provides products and services in more than 50 countries throughout the world, and a second license agreement was signed with one of the largest animal vaccine manufacturers in Japan, both to evaluate the potential of EB66® cells to produce new vaccines.

 

Read the press release

 

 

valvena photos pied de page